Evgen Pharma plc

Evgen Pharma plc

EVG.L
Evgen Pharma plcGB flagLondon Stock Exchange
0.82
GBp
+0.02
- -
3.50MMarket Cap

Evgen Pharma plc (EVG.L) Stock Splits

Learn about Evgen Pharma plc's most recent 507-for-500 basis stock split on February 12, 2021. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Evgen Pharma plc's most recent stock split

Split Date: 2021-02-12
Split Ratio: 507:500
Price Before Split: $9.33
Price After Split: $9.20

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.01 times more shares (a 507:500 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Evgen Pharma plc's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2021-02-12507:500No$9.33$9.20

About Evgen Pharma plc

Company overview and industry information

Evgen Pharma plc (EVG.L) operates in the Biotechnology industry. The recent 507-for-500 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Biotechnology
Go to Evgen Pharma plc Summary

Last updated: 6/3/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.